Contact Us
Cannabis Science, Inc.
6946 North Academy Boulevard
Suite B #254
Colorado Springs, CO 80918
Email: info@cannabisscience.com
Tel: +1 (888) 777-0658
Fax: +1 (866) 943-5085
INVESTOR INQUIRIES
Robert Kane - CFO & Director
Email: robert.kane@cannabisscience.com
Tel: +1 (561) 420-4824
AUTHORIZED SHARES
Common Class B
850,000,000
Common Class A
100,000,000
Preferred
1,000,000
SHARES OUTSTANDING
Common, Class B
29,744,774 a/o Dec 32, 2009
101,170,574 a/o Dec 31, 2010
305,820,574 a/o Dec 31, 2011
602,170,573 a/o May 21, 2012
691,770,573 a/o Aug 13, 2012
699,290,000 a/o Nov 8, 2012
714,540,573 a/o Nov 19, 2012
704,290,573 a/o Dec 17, 2012
823,523,000 a/o Mar 13, 2014
2,327,855,296 a/o Sep 30, 2016
Common, Class A
0
Preferred
1,000,000
Stock Chart
====================================================
2019...SEVERELY DELINQUENT FILINGS
https://www.otcmarkets.com/stock/CBIS/disclosure
2014 Financial Highlights (from 10-K)
Net Loss $ 16,884,764 (2013: $ 5,934,301)
Accumulated Deficit $ 109,393,306 (2013: $ 92,508,542)
Revenue (educational and consulting) $ 1,031
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=10637231
2015 (9 months) Highlights:
Revenue $4,150,
Gen&Admin $8,710,982
Net Loss $14,204,900 !!
https://www.facebook.com/CBISinc/
Sept 2016
The accompanying consolidated financial statements have been prepared in conformity with generally accepted accounting principles, which contemplate the continuation of the Company as a going concern. The Company reported an accumulated deficit of $139,971,991and had a stockholders’ deficit of $4,344,643 as of September 30, 2016.
Is this CBIS International Headquarters, Research Center??
